| Gene expression signature quantifies the cellular contribution of the tumor vs. the microenvironment in determining colorectal cancer prognosis and therapeutic … M Yang, TJ Yeatman, MV Nebozhyn, MJ Schell, L Pflieger, A Loboda, ... Cancer Research 84 (6_Supplement), 6430-6430, 2024 | | 2024 |
| Adenomatous polyposis coli (APC) regulates miR17-92 cluster through beta-catenin pathway in colorectal cancer (vol 35, Pg 4558-4568, 2016) Y Li, M Lauriola, D Kim, M Francesconi, G D'Uva, D Shibata, MP Malafa, ... ONCOGENE 43 (11), 838-838, 2024 | | 2024 |
| Editorial Expression of Concern: Adenomatous polyposis coli (APC) regulates miR17-92 cluster through β-catenin pathway in colorectal cancer Y Li, M Lauriola, D Kim, M Francesconi, G D'Uva, D Shibata, MP Malafa, ... Oncogene 43 (11), 837, 2024 | | 2024 |
| High-resolution transcriptional signature to predict survival benefit in colorectal cancer (CRC) treated with EGFR inhibitors (EGFRi) independent of RAS/BRAF mutation status or … R Thota, T Yeatman, N Gandhi, M Yang, M Schell, L Pflieger, A Loboda, ... Journal of Clinical Oncology 42 (3_suppl), 203-203, 2024 | | 2024 |
| APC as a high-utility mutational biomarker that may identify subpopulations of patients with mutant RAS/BRAF and right-sided colorectal cancer (CRC) who derive … R Thota, T Yeatman, N Gandhi, M Yang, M Schell, L Pflieger, A Loboda, ... Journal of Clinical Oncology 42 (3_suppl), 56-56, 2024 | | 2024 |
| p21 protein outperforms clinico-pathological criteria in predicting liver metastases in pancreatic endocrine tumors A Nasir, MK Ahmed, JJ Saller, EB Henderson-Jackson, MP Malafa, ... Cancer Genomics & Proteomics 20 (6), 522-530, 2023 | 1 | 2023 |
| Development of an APC and TP53-based duplex sequencing assay to positively predict colorectal cancer response to EGFR inhibitors M Yang, MJ Schell, L Pflieger, J Salk, TJ Yeatman Cancer Research 83 (7_Supplement), 4343-4343, 2023 | | 2023 |
| Evaluation of cell-free DNA approaches for multi-cancer early detection A Jamshidi, MC Liu, EA Klein, O Venn, E Hubbell, JF Beausang, S Gross, ... Cancer Cell 40 (12), 1537-1549. e12, 2022 | 110 | 2022 |
| Hotspot mutations of TP53 sensitize APC-mutated colorectal cancer cells to cetuximab in vitro M Yang, H Wang, TB Davis, L Pflieger, R Thota, WJ Pledger, TJ Yeatman Cancer Research 82 (12_Supplement), 5366-5366, 2022 | | 2022 |
| Colorectal cancer recurrence gene expression signature M Schell, T Yeatman US Patent App. 17/347,003, 2022 | | 2022 |
| Interaction of lncRNA MIR100HG with hnRNPA2B1 facilitates m6A-dependent stabilization of TCF7L2 mRNA and colorectal cancer progression H Liu, D Li, L Sun, H Qin, A Fan, L Meng, R Graves-Deal, SE Glass, ... Molecular cancer 21 (1), 74, 2022 | 91 | 2022 |
| Ras Pathway Activation and MEKi Resistance Scores Predict the Efficiency of MEKi and SRCi Combination to Induce Apoptosis in Colorectal Cancer TB Davis, S Gupta, M Yang, L Pflieger, M Rajan, H Wang, R Thota, ... Cancers 14 (6), 1451, 2022 | 4 | 2022 |
| An integrative gene expression signature analysis identifies CMS4 KRAS-mutated colorectal cancers sensitive to combined MEK and SRC targeted therapy M Yang, TB Davis, L Pflieger, MV Nebozhyn, A Loboda, H Wang, ... BMC cancer 22 (1), 256, 2022 | 6 | 2022 |
| Immune Gene Signatures in Cancer JJ Mulé, D Coppola, TJ Yeatman, A Loboda, MV Nebozhyn US Patent App. 17/330,177, 2021 | | 2021 |
| APC and TP53 Mutations Predict Cetuximab Sensitivity across Consensus Molecular Subtypes R Thota, M Yang, L Pflieger, MJ Schell, M Rajan, TB Davis, H Wang, ... Cancers 13 (21), 5394, 2021 | 10 | 2021 |
| 1123O Evaluation of cell-free DNA approaches for multi-cancer early detection MC Liu, A Jamshidi, EA Klein, O Venn, E Hubbell, JF Beausang, N Zhang, ... Annals of Oncology 32, S921, 2021 | 2 | 2021 |
| A novel role of SRC in mediating bypass resistance to MEK inhibition in colorectal cancer stem cells M Yang, TBDB Davis, MV Nebozhyn, A Loboda, H Wang, MJ Schell, ... Cancer Research 81 (13_Supplement), 1083-1083, 2021 | 1 | 2021 |
| Colorectal cancer recurrence gene expression signature M Schell, T Yeatman US Patent 11,035,006, 2021 | 2 | 2021 |
| Immune related biomarkers in biliary tract cancers (BTC). Z Sandhu, J Sanchez-Garcia, T Barker, S Raghunath, K Shortt, SH Hwang, ... Journal of Clinical Oncology 39 (15_suppl), e16191-e16191, 2021 | 1 | 2021 |
| Immune Gene Signatures in Cancer JJ Mulé, D Coppola, TJ Yeatman, A Loboda, MV Nebozhyn US Patent App. 16/868,293, 2020 | | 2020 |
